Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

121 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Conditional survival in multiple myeloma and impact of prognostic factors over time.
Abdallah NH, Smith AN, Geyer S, Binder M, Greipp PT, Kapoor P, Dispenzieri A, Gertz MA, Baughn LB, Lacy MQ, Hayman SR, Buadi FK, Dingli D, Hwa YL, Lin Y, Kourelis T, Warsame R, Kyle RA, Rajkumar SV, Kumar SK. Abdallah NH, et al. Among authors: hwa yl. Blood Cancer J. 2023 May 15;13(1):78. doi: 10.1038/s41408-023-00852-4. Blood Cancer J. 2023. PMID: 37188699 Free PMC article.
DNA hypermethylation as a chemotherapy target.
Ren J, Singh BN, Huang Q, Li Z, Gao Y, Mishra P, Hwa YL, Li J, Dowdy SC, Jiang SW. Ren J, et al. Among authors: hwa yl. Cell Signal. 2011 Jul;23(7):1082-93. doi: 10.1016/j.cellsig.2011.02.003. Epub 2011 Feb 21. Cell Signal. 2011. PMID: 21345368 Review.
Tumor markers for early detection of ovarian cancer.
Ren J, Cai H, Li Y, Zhang X, Liu Z, Wang JS, Hwa YL, Zhang Y, Yang Y, Li Y, Jiang SW. Ren J, et al. Among authors: hwa yl. Expert Rev Mol Diagn. 2010 Sep;10(6):787-98. doi: 10.1586/erm.10.39. Expert Rev Mol Diagn. 2010. PMID: 20843202 Review.
Nonhistone protein acetylation as cancer therapy targets.
Singh BN, Zhang G, Hwa YL, Li J, Dowdy SC, Jiang SW. Singh BN, et al. Among authors: hwa yl. Expert Rev Anticancer Ther. 2010 Jun;10(6):935-54. doi: 10.1586/era.10.62. Expert Rev Anticancer Ther. 2010. PMID: 20553216 Free PMC article. Review.
Treatment of Immunoglobulin Light Chain Amyloidosis: Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus Statement.
Dispenzieri A, Buadi F, Kumar SK, Reeder CB, Sher T, Lacy MQ, Kyle RA, Mikhael JR, Roy V, Leung N, Grogan M, Kapoor P, Lust JA, Dingli D, Go RS, Hwa YL, Hayman SR, Fonseca R, Ailawadhi S, Bergsagel PL, Chanan-Khan A, Rajkumar SV, Russell SJ, Stewart K, Zeldenrust SR, Gertz MA. Dispenzieri A, et al. Among authors: hwa yl. Mayo Clin Proc. 2015 Aug;90(8):1054-81. doi: 10.1016/j.mayocp.2015.06.009. Mayo Clin Proc. 2015. PMID: 26250727 Review.
Risk factors for and outcomes of patients with POEMS syndrome who experience progression after first-line treatment.
Kourelis TV, Buadi FK, Gertz MA, Lacy MQ, Kumar SK, Kapoor P, Go RS, Lust JA, Hayman SR, Rajkumar V, Zeldenrust SR, Russell SJ, Dingli D, Lin Y, Leung N, Hwa YL, Gonsalves W, Kyle RA, Dispenzieri A. Kourelis TV, et al. Among authors: hwa yl. Leukemia. 2016 May;30(5):1079-85. doi: 10.1038/leu.2015.344. Epub 2015 Dec 16. Leukemia. 2016. PMID: 26669974
121 results